Invesco
AGL icon

Invesco’s Agilon Health AGL Stock Holding History

Invesco’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
133,144
+92,608
+228% +$6.07M ﹤0.01% 1703
2026
Q1 		$321K Buy
40,536
+365
+0.9% +$5.9K ﹤0.01% 3313
2025
Q4 		$692K Buy
40,171
+9,438
+31% +$183K ﹤0.01% 3069
2025
Q3 		$791K Buy
30,733
+3,206
+12% +$121K ﹤0.01% 3032
2025
Q2 		$1.58M Sell
27,527
-18,545
-40% -$1.49M ﹤0.01% 2658
2025
Q1 		$4.99M Buy
46,072
+30,002
+187% +$2.61M ﹤0.01% 2150
2024
Q4 		$763K Buy
16,070
+38
+0.2% +$2.3K ﹤0.01% 3032
2024
Q3 		$1.58M Sell
16,032
-9,396
-37% -$1.21M ﹤0.01% 2714
2024
Q2 		$4.16M Buy
25,428
+5,581
+28% +$795K ﹤0.01% 2290
2024
Q1 		$3.03M Buy
19,847
+9,749
+97% +$1.62M ﹤0.01% 2484
2023
Q4 		$3.17M Sell
10,098
-3,131
-24% -$1.13M ﹤0.01% 2452
2023
Q3 		$5.87M Buy
13,229
+4,193
+46% +$1.89M ﹤0.01% 2119
2023
Q2 		$3.92M Sell
9,036
-3,929
-30% -$2.21M ﹤0.01% 2359
2023
Q1 		$7.7M Buy
12,965
+6,912
+114% +$3.87M ﹤0.01% 1991
2022
Q4 		$2.44M Buy
6,053
+888
+17% +$416K ﹤0.01% 2567
2022
Q3 		$3.02M Sell
5,165
-202
-4% -$121K ﹤0.01% 2463
2022
Q2 		$2.93M Buy
5,367
+865
+19% +$437K ﹤0.01% 2546
2022
Q1 		$2.85M Hold
4,502
– – ﹤0.01% 2640
2021
Q4 		$3.04M Buy
4,502
+2,153
+92% +$1.31M ﹤0.01% 2629
2021
Q3 		$1.54M Buy
2,349
+1,262
+116% +$1.08M ﹤0.01% 2929
2021
Q2 		$1.1M Buy
+1,087
New +$952K ﹤0.01% 3091

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Invesco's AGL Position: Q2 2026 in Review

Invesco increased its Agilon Health (AGL) stake by 228% in Q2 2026, buying an estimated $6.07M and bringing the position to 133,144 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

Invesco first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Invesco held 133,144 shares of Agilon Health worth $14.3M as of Q2 2026.
  • Invesco bought 92,608 Agilon Health shares in Q2 2026, an estimated $6.07M.
  • Agilon Health made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1703 holding.
  • Invesco first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.